Gelone Steven P. 4
4 · Nabriva Therapeutics plc · Filed Sep 1, 2022
Insider Transaction Report
Form 4
Gelone Steven P.
Chief Development Officer
Transactions
- Tax Payment
Ordinary Shares
2022-08-31$0.16/sh−61$10→ 361,400 total
Footnotes (1)
- [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.